QasimW, AmroliaPJ, SamarasingheS, et al.First clinical application of TALEN engineered universal CAR19 T cells in B-ALL. Abstract to be presented at the 57th American Society of Hematology Annual MeetingDecember 5, 2015. Available at: https://ash.confex.com/ash/2015/webprogram/Paper81653.html
2.
MausMV, GruppSA, PorterDL, et al.Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood, 2014; 123:2625–2635.
